Analysen von Matthew Weston

15.01.24 Sartorius vz. Neutral UBS AG
15.01.24 Roche Neutral UBS AG
18.04.23 Sartorius vz. Neutral Credit Suisse Group
16.10.20 Roche Neutral Credit Suisse Group
08.10.20 Roche Neutral Credit Suisse Group
24.07.20 Roche Neutral Credit Suisse Group
23.04.20 Roche Neutral Credit Suisse Group
25.11.19 Novartis Neutral Credit Suisse Group
25.04.19 Novartis Neutral Credit Suisse Group
05.04.19 Novartis Neutral Credit Suisse Group
25.02.19 Roche Neutral Credit Suisse Group
31.01.19 Novartis Neutral Credit Suisse Group
28.01.19 Roche Neutral Credit Suisse Group
19.10.18 Novartis Neutral Credit Suisse Group
09.08.18 Novo Nordisk Neutral Credit Suisse Group
19.07.18 Novartis Neutral Credit Suisse Group
18.04.18 Roche Neutral Credit Suisse Group
24.01.18 Novartis Neutral Credit Suisse Group
31.10.16 Novo Nordisk Neutral Credit Suisse Group
08.08.16 Novo Nordisk Neutral Credit Suisse Group
19.10.11 Merck neutral Credit Suisse Group
28.07.11 Merck neutral Credit Suisse Group